See more : Tantalus Systems Holding Inc. (GRID.TO) Income Statement Analysis – Financial Results
Complete financial analysis of Adastra Holdings Ltd. (XTXXF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Adastra Holdings Ltd., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- Teradata Corporation (0LEE.L) Income Statement Analysis – Financial Results
- Public Storage (PSA-PP) Income Statement Analysis – Financial Results
- Decai Decoration CO.,LTD (605287.SS) Income Statement Analysis – Financial Results
- Friday’s Dog Holdings Inc. (FDOGF) Income Statement Analysis – Financial Results
- Deep Energy Resources Limited (DEEPENR.BO) Income Statement Analysis – Financial Results
Adastra Holdings Ltd. (XTXXF)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.adastraholdings.ca
About Adastra Holdings Ltd.
Adastra Holdings Ltd. operates as a cannabis extraction and processing solutions company. The company offers cannabis analytical testing, and cannabis processing services. It provides processing solutions to licensed cultivators of cannabis and hemp; and supplies cannabis extracts to qualified Canadian and international business-to-business partners. The company was formerly knowns as Phyto Extractions Inc. and changed its name to Adastra Holdings Ltd. in September 2021. Adastra Holdings Ltd. was incorporated in 1987 and is based in Langley, Canada.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 22.22M | 13.30M | 5.63M | 2.50M | 0.00 |
Cost of Revenue | 15.19M | 7.18M | 3.68M | 1.71M | 78.17K |
Gross Profit | 7.03M | 6.11M | 1.94M | 785.58K | -78.17K |
Gross Profit Ratio | 31.64% | 45.97% | 34.53% | 31.43% | 0.00% |
Research & Development | 0.00 | 0.00 | 89.27K | 181.75K | 5.20K |
General & Administrative | 4.26M | 4.91M | 3.38M | 6.86M | 941.58K |
Selling & Marketing | 4.20M | 1.28M | 455.09K | 749.26K | 85.23K |
SG&A | 8.46M | 6.19M | 3.84M | 7.61M | 1.04M |
Other Expenses | 364.30K | -1.52M | 53.40K | -63.17K | 0.00 |
Operating Expenses | 8.82M | 6.91M | 4.34M | 7.89M | 1.04M |
Cost & Expenses | 24.02M | 14.10M | 8.02M | 9.60M | 1.12M |
Interest Income | 0.00 | 0.00 | 0.00 | 8.30K | 7.76K |
Interest Expense | 1.04M | 343.92K | 276.60K | 457.65K | 241.21K |
Depreciation & Amortization | 1.41M | 1.38M | 1.10M | 92.70K | 78.17K |
EBITDA | -1.41M | 559.89K | -1.30M | -6.59M | -1.56M |
EBITDA Ratio | -6.35% | -7.11% | -22.03% | -280.11% | 0.00% |
Operating Income | -1.79M | -800.00K | -2.39M | -7.16M | -1.12M |
Operating Income Ratio | -8.07% | -6.02% | -42.49% | -286.48% | 0.00% |
Total Other Income/Expenses | -2.07M | -3.54M | -373.20K | -450.85K | -1.54M |
Income Before Tax | -3.86M | -4.34M | -2.76M | -7.62M | -2.66M |
Income Before Tax Ratio | -17.38% | -32.63% | -49.12% | -304.71% | 0.00% |
Income Tax Expense | -317.00K | -56.00K | -15.00K | 457.65K | -2.00 |
Net Income | -3.54M | -4.28M | -2.75M | -7.62M | -2.66M |
Net Income Ratio | -15.95% | -32.20% | -48.86% | -304.71% | 0.00% |
EPS | -0.06 | -0.07 | -0.05 | -0.19 | -0.10 |
EPS Diluted | -0.06 | -0.07 | -0.05 | -0.19 | -0.10 |
Weighted Avg Shares Out | 55.97M | 59.23M | 50.23M | 39.70M | 27.50M |
Weighted Avg Shares Out (Dil) | 55.97M | 59.23M | 50.23M | 39.70M | 27.50M |
Source: https://incomestatements.info
Category: Stock Reports